ALEZURIS Trademark

Trademark Overview


On Friday, January 14, 2022, a trademark application was filed for ALEZURIS with the United States Patent and Trademark Office. The USPTO has given the ALEZURIS trademark a serial number of 97220752. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 1, 2023. This trademark is owned by Tricida, Inc.. The ALEZURIS trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations for the treatment of metabolic acidosis associated with chronic kidney disease; pharmaceutical preparations for the treatment of renal diseases and disorders; pharmaceutical preparations for increasing bicarbonate levels; non-absorbed pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of metabolic acidosis and renal disorders; polymeric pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of metabolic acidosis and renal disorders; non-absorbed polymer for treatment of metabolic acidosis associated with kidney disease
alezuris

General Information


Serial Number97220752
Word MarkALEZURIS
Filing DateFriday, January 14, 2022
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 1, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 2, 2022

Trademark Statements


Goods and Servicespharmaceutical preparations for the treatment of metabolic acidosis associated with chronic kidney disease; pharmaceutical preparations for the treatment of renal diseases and disorders; pharmaceutical preparations for increasing bicarbonate levels; non-absorbed pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of metabolic acidosis and renal disorders; polymeric pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of metabolic acidosis and renal disorders; non-absorbed polymer for treatment of metabolic acidosis associated with kidney disease

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, January 21, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameTricida, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Party NameTricida, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events


Event DateEvent Description
Monday, May 1, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, May 1, 2023ABANDONMENT - NO USE STATEMENT FILED
Tuesday, September 27, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 2, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 2, 2022PUBLISHED FOR OPPOSITION
Wednesday, July 13, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 28, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 28, 2022ASSIGNED TO EXAMINER
Friday, January 21, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, January 18, 2022NEW APPLICATION ENTERED